| Literature DB >> 35777411 |
Hiam Chemaitelly1, Houssein H Ayoub2, Ryosuke Omori3, Shereen El Feki4, Joumana G Hermez5, Helen A Weiss6, Laith J Abu-Raddad7.
Abstract
BACKGROUND: The incidence of HIV infection among female sex workers and their clients in the Middle East and north Africa is not well known. We aimed to assess HIV incidence, the contribution of heterosexual sex work networks to these numbers, and the effect of interventions by use of mathematical modelling.Entities:
Mesh:
Year: 2022 PMID: 35777411 PMCID: PMC9253890 DOI: 10.1016/S2352-3018(22)00100-X
Source DB: PubMed Journal: Lancet HIV ISSN: 2352-3018 Impact factor: 16.070
Figure 1Basic structure of the model describing HIV transmission dynamics in female sex workers, clients, and client spouses
ART=antiretroviral therapy.
HIV epidemiological measures for female sex workers, clients, and client spouses in countries in the Middle East and north Africa with no significant HIV transmission through injecting drug use among female sex workers, 2020
| Population | |||||||||||
| Female sex workers (n) | 65 969 | 4481 | 72 000 | 36 174 | 110 968 | 212 500 | 25 500 | 58 934 | |||
| Female sex workers (proportion; %) | 0·6% | 1·7% | 0·8% | 1·0% | 4·1% | 2·0% | 0·9% | 1·6% | |||
| Clients of female sex workers (n) | 659 690 | 44 810 | 720 000 | 361 740 | 1 109 680 | 2 125 000 | 255 000 | 589 340 | |||
| HIV prevalence among all female sex workers (empirical data; %) | 4·9% | 9·3% | 2·2% | 4·5% | 37·9% | 1·5% | 1·2% | 0·8% | |||
| HIV incidence in the total adult population per year as estimated by UNAIDS | 2000 | <100 | <1000 | <500 | 16 000 | 2900 | <1000 | 1000 | |||
| Current HIV intervention coverage (%) | |||||||||||
| Condom use (empirical data) | 65·3% | 59·6% | 52·3% | 31·5% | 72·4% | 26·0% | 58·3% | 46·0% | |||
| Male circumcision (empirical data) | 97·9% | 96·5% | 99·9% | 93·5% | 23·6% | 90·7% | 99·8% | 99·0% | |||
| ART (empirical data) | |||||||||||
| Female sex workers | 32·0% | 30·0% | 57·0% | 28·0% | 9·4% | 15·0% | 31·0% | 21·0% | |||
| Clients or people living with HIV | 32·0% | 30·0% | 57·0% | 28·0% | 16·0% | 15·0% | 31·0% | 21·0% | |||
| PrEP (empirical data) | |||||||||||
| Female sex workers | 0·0% | 0·0% | 0·0% | 0·0% | 0·0% | 0·0% | 0·0% | 0·0% | |||
| Clients | 0·0% | 0·0% | 0·0% | 0·0% | 0·0% | 0·0% | 0·0% | 0·0% | |||
| HIV prevalence (%) | |||||||||||
| All female sex workers | 4·9% (0·8–12·8%) | 9·2% (3·3–16·0%) | 2·2% (0·5–8·0%) | 4·6% (0·8–13·1%) | 38·2% (32·2–43·5%) | 1·5% (0·3–9·7%) | 1·4% (0·2–8·3%) | 0·7% (0·2–6·0%) | |||
| Clients of female sex workers | 1·3% (0·2–3·3%) | 2·4% (0·8–4·3%) | 0·5% (0·1–1·9%) | 1·1% (0·2–3·0%) | 16·9% (14·0–19·2%) | 0·3% (0·07–2·3%) | 0·4% (0·07–2·1%) | 0·2% (0·1–1·7%) | |||
| Client spouses | 0·4% (0·1–1·1%) | 0·8% (0·3–1·4%) | 0·2% (0·03–0·6%) | 0·4% (0·1–1·0%) | 5·6% (4·7–6·4%) | 0·1% (0·02–0·8%) | 0·1% (0·02–0·7%) | 0·06% (0·0–0·6%) | |||
| HIV incidence in heterosexual sex work networks per year (n) | |||||||||||
| All female sex workers | 179 (0–770) | 21 (0–60) | 83 (0–600) | 93 (0–422) | 2345 (1295–3884) | 163 (0–1771) | 21 (0–170) | 26 (0–393) | |||
| Clients of female sex workers | 234 (0–770) | 29 (0–67) | 100 (0–600) | 113 (0–422) | 5167 (3144–7398) | 213 (0–2125) | 25 (0–213) | 30 (0–393) | |||
| Client spouses | 173 (31–431) | 22 (7–39) | 61 (11–217) | 84 (15–266) | 3978 (3330–4484) | 166 (32–1082) | 18 (4–108) | 26 (10–235) | |||
| HIV incidence rate | |||||||||||
| All female sex workers | 2·9 (0·0–13·2) | 5·1 (0·0–14·8) | 1·2 (0·0–8·7) | 2·8 (0·0–12·5) | 34·3 (17·2–59·6) | 0·8 (0·0–8·8) | 0·9 (0·0–7·3) | 0·4 (0·0–7·1) | |||
| Clients of female sex workers | 0·2 (0·0–0·6) | 0·3 (0·0–0·8) | 0·07 (0·0–0·4) | 0·2 (0·0–0·6) | 2·5 (1·5–3·6) | 0·05 (0·0–0·5) | 0·05 (0·0–0·4) | 0·03 (0·0–0·3) | |||
| Client spouses | 0·5 (0·08–1·2) | 0·9 (0·3–1·6) | 0·2 (0·03–0·6) | 0·4 (0·07–1·1) | 6·7 (5·6–7·7) | 0·1 (0·03–0·9) | 0·1 (0·02–0·8) | 0·07 (0·03–0·7) | |||
| Contribution to total HIV incidence in the population (%) | |||||||||||
| All female sex workers | 9·0% (0·0–38·5%) | 21·2% (0·0–60·6%) | 8·3% (0·0–60·1%) | 18·6% (0·0–84·6%) | 14·7% (8·1–24·3%) | 5·6% (0·0–61·1%) | 2·1% (0·0–17·0%) | 2·6% (0·0–39·3%) | |||
| Clients of female sex workers | 11·7% (0·0–38·5%) | 29·3% (0·0–67·7%) | 10·0% (0·0–60·1%) | 22·6% (0·0–84·6%) | 32·3% (19·7–46·2%) | 7·3% (0·0–73·3%) | 2·5% (0·0–21·3%) | 3·0% (0·0–39·3%) | |||
| Client spouses | 8·7% (1·6–21·6%) | 22·2% (7·1–39·4%) | 6·1% (1·1–21·7%) | 16·8% (3·0–53·3%) | 24·9% (20·8–28·0%) | 5·7% (1·1–37·3%) | 1·8% (0·4–10·8%) | 2·6% (1·0–23·5%) | |||
| Heterosexual sex work networks | 29·3% (1·6–98·6%) | 72·7% (7·1–100%) | 24·4% (1·1–100%) | 58·1% (3·0–100%) | 71·8% (48·6–98·5%) | 18·7% (1·1–100%) | 6·4% (0·4–49·1%) | 8·2% (1·0–100%) | |||
Data are n (95% UI), or % (95% UI) unless otherwise specified. Numbers are rounded to the first decimal unless the number was <0·1%. The table includes measures based on empirical data for model input, as well as measures estimated using the model. ART=antiretroviral therapy. PrEP=pre-exposure prophylaxis. UI=uncertainty interval.
Proportion of female sex workers out of total reproductive-age women aged 15–49 years.
Estimates for the number of new infections occurring in the population per year were provided by UNAIDS. Assumed to be 99 where incidence is reported as <100, 499 where incidence is reported as <500, and 999 where incidence is reported as <1000.
Numbers of new HIV infections per susceptible person per 1000 person-years.
HIV epidemiological measures among female sex workers, clients, and client spouses in countries in the Middle East and north Africa with significant HIV transmission through injecting drug use among female sex workers, 2020
| Population | ||||||
| Female sex workers (n) | 2143 | 91 500 | 11 459 | 228 800 | ||
| Female sex workers (proportion; %) | 0·6% | 1·4% | 0·6% | 0·4% | ||
| Clients of female sex workers (n) | 21 430 | 915 000 | 114 590 | 2 288 000 | ||
| Proportion of female sex workers who inject drugs (%) | 3·9% | 13·6% | 2·9% | 2·0% | ||
| HIV prevalence (empirical, %) | ||||||
| All female sex workers | 0·8% | 3·3% | 4·9% | 2·3% | ||
| Female sex workers who inject drugs | 21·0% | 9·9% | 44·0% | 38·4% | ||
| HIV incidence in the total adult population per year as estimated by UNAIDS | Unknown | 4000 | <500 | 23 000 | ||
| Current HIV interventions' coverage (%) | ||||||
| Condom use (empirical data) | 44·0% | 57·1% | 80·0% | 50·5% | ||
| Male circumcision (empirical data) | 81·2% | 99·7% | 96·6% | 96·4% | ||
| ART (empirical data) | ||||||
| Female sex workers | 45·0% | 20·0% | 44·0% | 8·0% | ||
| Clients or people living with HIV | 45·0% | 20·0% | 44·0% | 8·0% | ||
| PrEP (empirical data) | ||||||
| Female sex workers | 0·0% | 0·0% | 0·0% | 0·0% | ||
| Clients | 0·0% | 0·0% | 0·0% | 0·0% | ||
| HIV prevalence (%) | ||||||
| All female sex workers | 0·9% (0·3–1·8%) | 3·3% (1·3–6·3%) | 4·6% (1·8–8·3%) | 2·4% (0·7–5·0%) | ||
| Female sex workers who inject drugs | 20·2% (8·0–37·0%) | 9·9% (3·4–17·8%) | 44·8% (21·1–68·8%) | 37·8% (11·1–66·7%) | ||
| Clients of female sex workers | 0·03% (0·0–0·08%) | 0·3% (0·1–0·6%) | 0·5% (0·2–1·0%) | 0·2% (0·05–0·6%) | ||
| Client spouses | 0·01% (0·0–0·03%) | 0·1% (0·03–0·2%) | 0·2% (0·07–0·3%) | 0·08% (0·02–0·2%) | ||
| HIV incidence in heterosexual sex work networks per year (n) | ||||||
| All female sex workers | 1 (0–7) | 172 (0–610) | 28 (0–96) | 339 (0–1525) | ||
| Female sex workers who inject drugs | 1 (0–7) | 55 (0–305) | 7 (0–38) | 110 (0–763) | ||
| Clients of female sex workers | <1 (0–4) | 171 (0–610) | 33 (0–96) | 301 (0–1525) | ||
| Client spouses | <1 (0–1) | 64 (20–127) | 11 (5–20) | 114 (25–278) | ||
| HIV incidence rate | ||||||
| All female sex workers | 0·5 (0·0–3·4) | 2·0 (0·0–7·1) | 2·6 (0·0–8·8) | 1·5 (0·0–6·9) | ||
| Female sex workers who inject drugs | 15·2 (0·0–117·6) | 5·1 (0·0–35·1) | 43·4 (0·0–300·0) | 45·8 (0·0–428·6) | ||
| Clients of female sex workers | 0·02 (0·0–0·2) | 0·2 (0·0–0·7) | 0·3 (0·0–0·8) | 0·1 (0·0–0·7) | ||
| Client spouses | 0·01 (0·0–0·03) | 0·1 (0·04–0·3) | 0·2 (0·07–0·3) | 0·09 (0·02–0·2) | ||
| Contribution to HIV incidence in female sex workers (%) | ||||||
| Sexual transmission | 14·5% | 68·0% | 75·0% | 67·6% | ||
| Injecting drug use | 85·5% | 32·0% | 25·0% | 32·4% | ||
| Contribution to total HIV incidence in the population (%) | ||||||
| All female sex workers | .. | 4·3% (0·0–15·3%) | 5·6% (0·0–19·2%) | 1·5% (0·0–6·6%) | ||
| Injecting drug use in female sex workers | .. | 1·4% (0·0–7·6%) | 1·4% (0·0–7·6%) | 0·5% (0·0–3·3%) | ||
| Clients of female sex workers | .. | 4·3% (0·0–15·3%) | 6·6% (0·0–19·2%) | 1·3% (0·0–6·6%) | ||
| Client spouses | .. | 1·6% (0·5–3·2%) | 2·2% (1·0–4·0%) | 0·5% (0·1–1·2%) | ||
| Heterosexual sex work networks | .. | 10·2% (0·5–33·7%) | 14·4% (1·0–42·5%) | 3·3% (0·1–14·5%) | ||
Data are n (95% UI) or % (95% UI) unless otherwise specified. Numbers are rounded to the first decimal unless the number was <0·1%. The table includes measures based on empirical data for model input, as well as measures estimated using the model. ART=antiretroviral therapy. PrEP=pre-exposure prophylaxis. UI=uncertainty interval.
Proportion of female sex workers out of total reproductive-age women aged 15–49 years.
Estimates for the number of new infections occurring in the population per year were provided by UNAIDS. Assumed to be 499 where incidence is reported as <500.
Numbers of new HIV infections per susceptible person per 1000 person-years.
Including female sex workers who inject drugs.
Figure 2Estimated effect of expanding coverage of HIV prevention and treatment interventions among female sex workers on HIV incidence in the Middle East and north Africa
PrEP=pre-exposure prophylaxis. ART=antiretroviral therapy. *Moderately optimistic scenario that includes expanding PrEP to 25%, condom use to 50%, ART to 50% (assuming efficacy of 96%, that is optimal adherence), and voluntary male circumcision to 50% (in South Sudan). †Most optimistic scenario that includes expanding PrEP to 50%, condom use to 80%, ART to 81% (assuming efficacy of 96%, that is optimal adherence), and voluntary male circumcision to 80% (in South Sudan).
Select modelled HIV prevention intervention packages to control HIV incidence in female sex workers and clients in the Middle East and north Africa
| Expanding ART coverage in female sex workers and their injecting partners assuming real-world ART effectiveness in achieving viral suppression of 57% (real-world adherence to ART) | Increase to 25%; increase to 50%; increase to 81% (global target) | |
| Expanding ART coverage in female sex workers and their injecting partners assuming ART efficacy in preventing HIV transmission to partners of 96% (optimal adherence to ART) | Increase to 25%; increase to 50%; increase to 81% (global target) | |
| Increasing condom use coverage | Increase to 50%; increase to 80% | |
| Expanding VMMC coverage in clients (only South Sudan) | Increase to 50%; increase to 80% | |
| Expanding PrEP coverage in female sex workers | Increase to 25%; increase to 50% | |
| Moderately optimistic scenario | ||
| Expanding ART coverage in female sex workers and their injecting partners assuming ART efficacy in preventing HIV transmission to partners of 96%; increasing condom use coverage; expanding VMMC coverage in clients (only South Sudan); expanding PrEP coverage in female sex workers | Expanding ART coverage to 50% with efficacy in preventing HIV transmission to partners of 96%, increasing condom use to 50%, and increasing PrEP to 25%. Baseline coverage was used whenever it was higher than that set in the investigated scenario. For South Sudan only, this package also included increasing VMMC to 50% | |
| Most optimistic scenario | ||
| Expanding ART coverage in female sex workers and their injecting partners assuming ART efficacy in preventing HIV transmission to partners of 96%; increasing condom use coverage; expanding VMMC in clients (only South Sudan); expanding PrEP coverage in female sex workers | Expanding interventions to the highest modelled coverage levels, including expanding ART coverage to 81% with efficacy of 96%, increasing condom use to 80%, and increasing PrEP to 50%; for South Sudan only, this package also included increasing VMMC to 80% | |
ART=antiretroviral therapy. PrEP=pre-exposure prophylaxis. VMMC=voluntary medical male circumcision. Baseline coverage was used whenever it was higher than that set in the investigated scenario